Cardiovascular Pharmacotherapy Focus

QR Code

Cardiovascular Pharmacotherapy Focus

Saved in:

Bibliographic Details
Main Author:	Pablo Avanzas
Format:	article
Language:	EN
Published:	Radcliffe Medical Media 2019
Subjects:	Diseases of the circulatory (Cardiovascular) system RC666-701
Online Access:	https://doaj.org/article/d10ff26d0f3b4a458e2ed6b2720c8e4c
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
by: Mattia Cattaneo, et al.
Published: (2019)

24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
by: Hector Ventura
Published: (2020)

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
by: BMY Cheung, et al.
Published: (2020)

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
by: Jonathan Yap, et al.
Published: (2021)

Editorial: The EXCEL Trial
by: Pablo Avanzas, et al.
Published: (2021)

The ISCHEMIA Trial: And the Winner Is… the Patient
by: Pablo Avanzas, et al.
Published: (2021)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
by: Eliecer Coto, et al.
Published: (2021)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
by: Ramón Arroyo-Espliguero, et al.
Published: (2021)

Inflammation and Cardiovascular Disease: The Future
by: Natalie Arnold, et al.
Published: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
by: Hargun Kaur, et al.
Published: (2021)

Meditation and Cardiovascular Health: What is the Link?
by: Sebastian Schnaubelt, et al.
Published: (2019)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
by: Amelia Carro, et al.
Published: (2019)

COVID-19 Pandemic and Cardiovascular Disease
by: Aniket S Rali, et al.
Published: (2020)

The Association Between Psoriasis and Cardiovascular Diseases
by: Ahmed Zwain, et al.
Published: (2021)

Effects of aerospace environments on the cardiovascular system
by: Erdinç Ercan
Published: (2021)

Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies
by: Tonje Thorvaldsen, et al.
Published: (2019)

Porcelain aorta rupture after cardiopulmonary resuscitation
by: Iria Silva, et al.
Published: (2021)

Porcelain aorta rupture after cardiopulmonary resuscitation
by: Iria Silva, et al.
Published: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
by: Esmee ME Bovee, et al.
Published: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
by: Alberto J Lorenzatti, et al.
Published: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
by: Aniket S Rali, et al.
Published: (2021)

Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
by: Domenico D’Amario, et al.
Published: (2019)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
by: Aarti Thakkar, et al.
Published: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
by: Chris Wai Hang Lo, et al.
Published: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
by: Maki Komiyama, et al.
Published: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
by: Pensée Wu, et al.
Published: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
by: O. D. Ostroumova, et al.
Published: (2020)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
by: Koji Hasegawa, et al.
Published: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
by: Olusola A Orimoloye, et al.
Published: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
by: Yunqiu Jiang, et al.
Published: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
by: Alberto J Lorenzatti
Published: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
by: Rhian M. Touyz, MBBCh, PhD, et al.
Published: (2021)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
by: Soohyun Chang, et al.
Published: (2021)

COVID-19: a patient with cardiovascular disease at high risk
by: Irina E. Chazova, et al.
Published: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
by: Gianluigi Savarese
Published: (2019)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
by: Charles Amir German, et al.
Published: (2020)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
by: Ernest Spitzer, et al.
Published: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
by: BMY Cheung, et al.
Published: (2020)